Conagen Revenue and Competitors

Claim your profile

Boston, MA USA

Location

$30M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Conagen's estimated annual revenue is currently $11.9M per year.(i)
  • Conagen's estimated revenue per employee is $155,000
  • Conagen's total funding is $30M.

Employee Data

  • Conagen has 77 Employees.(i)
  • Conagen grew their employee count by -5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-94%N/AN/A
#2
$2.6M17N/AN/AN/A
#3
$6M39-20%$176.5MN/A
#4
$4.5M29N/AN/AN/A
#5
$2.6M17N/AN/AN/A
#6
N/A145-21%$39.5MN/A
#7
N/A0N/A$9.5MN/A
#8
$15.9M159-39%$135MN/A
#9
$1.7M1157%$20.9MN/A
#10
$2.8M1850%$28.9MN/A

Conagen Inc. is a leader in the area of bio-manufacturing. We engineer live organisms to produce molecules that are essential to our well-beings. Scientists and Engineers at Conagen use the latest synthetic biology tools to design metabolic pathways, improve production organisms, optimize production procedures, and ensure the quality as well as safety of the final products. We focus on bio-production of high value ingredients for food, nutrition, pharmaceutical, and renewable material industries. Science and Innovation are the driving forces of our Mission. Conagen is a discovery-based company. We are passionate about understanding and engineering metabolic pathways. Our scientists are equipped with unprecedented systemic information on cellular metabolisms. New automation systems and novel fermentation technologies are being developed to advance our bio-manufacturing capabilities. We are well-positioned to provide solutions for our customers, and are dedicated to bringing better products to the world.

keywords:N/A

$30M

Total Funding

77

Number of Employees

$11.9M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Conagen News

2022-03-30 - Conagen's Grant Award Opens New Markets for Monoclonal ...

Funding from the Bill & Melinda Gates Foundation for Conagen's Conamax platform benefits developing countries and patients globally. March 29,...

2022-03-30 - Conagen's Grant Award Opens New Markets for Monoclonal ...

Funding from the Bill & Melinda Gates Foundation for Conagen's Conamax platform benefits developing countries and patients globally. March 29,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.9M77-21%N/A
#2
$11.3M788%N/A
#3
$19.6M8019%N/A
#4
$16.3M818%N/A
#5
$12M83N/AN/A